期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

循环肿瘤细胞在乳腺癌中的研究进展 被引量：3

Circulating tumor cells in breast cancer
原文传递
导出
摘要 对于乳腺癌患者可以通过Cell Search系统自动检测外周血中循环肿瘤细胞（CTC）数目。近期相关研究的结果提示对于晚期乳腺患者而言，CTC水平可以用来预测患者预后并早期预测对治疗的反应。但是在早期乳腺癌中CTC的预测价值并不确切。进一步了解CTC的生物学特性以及明确其作为预后预测的应用价值仍需要大型前瞻性临床研究结果的揭示。 Circulating tumor cells （CTCs） in breast cancer patients can be detected by Cell Search system. Results from recent studies suggested that CTCs level might serve as a prognostic marker and be used in the early assessment of therapeutic response in patients with metastatic breast cancer. However the role of CTCs in early stage breast cancer is not well established. Large prospective trials are needed to further understand its biological characteristics and to confirm its role as a predictive and prognostic marker.
作者 黄红艳 江泽飞
机构地区 军事医学科学院附属医院乳腺肿瘤科
出处 《国际肿瘤学杂志》 CAS 2011年第7期516-518,共3页 Journal of International Oncology
基金 首都医学发展科研基金重点项目（2009-2044）
关键词 乳腺肿瘤 肿瘤循环细胞 预测 Breast neoplasms Neoplasm circulating cells Forecasting
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Krishnamurthy S, Cristofanilli M, Singh B, et al. Detection of mini- real residual disease in blood and bone marrow in early stage breast cancer. Cancer, 2010, 116(14) :3330-3337.
  • 2Miiller V, Alix-Panabieres C, Pantel K. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies. Eur J Cancer, 2010, 46(7) :1189-1197.
  • 3Ross JS, Slodkowska EA. Circulating and disseminated tumor cells in the management of breast cancer. Am J Clin Pathol, 2009, 132(2) : 237 -245.
  • 4Riethdorf S, Pantel K. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients : current state of detection and characterization. Pathobiology, 2008, 75 ( 2 ) : 140- 148.
  • 5Dawood S, Cristofanilli M. Integrating circulating tumor cell assays into the management of breast cancer. Curt Treat Options Oncol, 2007, 8(1) :89-95.
  • 6Chen Y, Zou TN, Wu ZP, et al. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonie antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer. Int J Biol Markers, 2010, 25(2) :59-68.
  • 7Saloustros E, Mavroudis D. Cytokeratin 19-positive circulating tumor cells in early breast cancer pi'ognosis. Future Oneol, 2010, 6 (2): 209-219.
  • 8Alvero AB, Burtness BA, Ercan AG, et al. Improved method for the detection of cytokeratin 19-positive cells in the peripheral blood of breast cancer patients. Lab Invest, 2004, 84(5 ) :658-661.
  • 9Hsieh HB, Marrinucci D, Bethel K, et al. High speed detection of circulating tumor cells. Biosens Bioelectron, 2006, 21 ( 10 ) : 1893- 1899.
  • 10Karl A, Tritsehler S, Hofmann S, et al. Perioperative search for circulating tumor cells in patients undergoing radical eystectomy for bladder cancer. Eur J Med Res, 2009,14( 11 ) :487-490.

同被引文献67

  • 1ASWORTH T R. A case of cancer in which cells similar to those in tumors were seen in the blood after death [J]. Aust Med J, 1869, 14: 146- 149.
  • 2LIU M C, SHIELDS P G, WARREN R D, et al. Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer [J]. J Clin Oncol, 2009, 27(31): 5153-5159.
  • 3JEMAL A, BRAY F, CENTER M M, et al. Glohal cancer statistics [J]. CA Cancer J Clin, 201 1, 61 (2): 69-90.
  • 4GANGOPADHYAY S, NANDY A, HOR P, et al. Breast cancer stem cells: a novel therapeutic target [J]. Clin Breast Cancer, 2013, 13(1): 7- 15.
  • 5WICHA M S, HAYES D F. Circulating tumor cells: not all detected cells are bad and not all had cells are detected [J]. J Clin Oncol, 20ll, 29(12): 1508-1511.
  • 6MOSTERT B, SLEIJFER S, FOEKENS J A, et al. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer [J]. Cancer Treat Rev, 2009, 35(5): 463-474.
  • 7LAMBRECHTS A C, BOSMA A J, KLAVER S G, et al. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-hased amplification for the detection of circulating breast cancer cells [J]. Breast Cancer Res Treat, 1999,56(3): 219-231.
  • 8SMITH B M, SLADE M J, ENGLISH J, et al. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitati ve polymerase chain reaction and immunocytochemical techniques [J]. J Clin Oncol, 2000,18(7): 1432-1439.
  • 9CRISTOFANILLI M, HAYES D F, BUDD G T, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer [J]. J Clin Oncol, 2005, 23(7): 1420-1430.
  • 10HAYES D F, CRISTOFANILLI M, BUDD G T, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival [J]. Clin Cancer Res, 2006, 12(14 Pt I): 4218-4224.

引证文献3

二级引证文献30

国际肿瘤学杂志
2011年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部